Biora Therapeutics Announces Reverse Stock Split
30 déc. 2022 09h00 HE
|
Biora Therapeutics, Inc.
SAN DIEGO, Dec. 30, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced it will effect a reverse stock...
Biora Therapeutics Announces Two Poster Presentations at the Crohn’s & Colitis Congress
08 déc. 2022 16h05 HE
|
Biora Therapeutics, Inc.
SAN DIEGO, Dec. 08, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced acceptance of two abstracts...
Biora Therapeutics Licenses Preeclampsia Rule-Out Test for Commercial Development
29 nov. 2022 09h00 HE
|
Biora Therapeutics, Inc.
SAN DIEGO, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced it has completed an agreement to...
Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2022 Financial Results
14 nov. 2022 16h01 HE
|
Biora Therapeutics, Inc.
Presented results of human study at the American College of Gastroenterology annual meeting, demonstrating promising device performance in active ulcerative colitis patients Executed a...
Biora Therapeutics to Report Third Quarter 2022 Financial Results and Provide Corporate Update
07 nov. 2022 16h15 HE
|
Biora Therapeutics, Inc.
SAN DIEGO, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced that it will report third quarter...
Biora Therapeutics Announces $9.75 Million Direct Offering
07 nov. 2022 08h06 HE
|
Biora Therapeutics, Inc.
SAN DIEGO, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced that it has entered into a...
Biora Therapeutics Announces Sale of Cell-Free DNA Patent Rights
27 oct. 2022 09h00 HE
|
Biora Therapeutics, Inc.
SAN DIEGO, Oct. 27, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced it has completed a one-time asset...
Biora Therapeutics Shares Data from Device Performance Study in Ulcerative Colitis Patients
25 oct. 2022 09h00 HE
|
Biora Therapeutics, Inc.
SAN DIEGO, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today presented detailed results from its PM-602...
Biora Therapeutics Shares Five Posters Presented at American College of Gastroenterology Annual Scientific Meeting 2022
24 oct. 2022 09h00 HE
|
Biora Therapeutics, Inc.
SAN DIEGO, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced the five posters presented at the...
Biora Therapeutics Shares Preclinical Data on Oral Delivery of Biologics at the 2022 Parenteral Drug Association Universe of Pre-Filled Syringes and Injection Devices Conference
19 oct. 2022 09h00 HE
|
Biora Therapeutics, Inc.
SAN DIEGO, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, today shared a poster presented at the Parenteral Drug...